University of California at Davis

Aberrant Behavior Checklist in Fragile X Syndrome

FRAXA Research Foundation 2006-2010 Grants • Clinical • Completed Research Grant • Hessl, David • University of California at Davis February 1, 2010August 2, 2018arbaclofen, autism

With a $10,000 grant from FRAXA Research Foundation, Dr. Hessl at the University of California at Davis led a collaborative study to analyze the Aberrant Behavior Checklist (ABC) as an outcome measure for children and adults with Fragile X syndrome. Results published.

Melatonin Clinical Trial in Fragile X

FRAXA Research Foundation 1994-2000 Grants • Clinical • Clinical Trials • Completed Research Grant • Disease Mechanisms • Hagerman, Randi • Treatment Targets • University of California at Davis February 27, 2000August 13, 2018autism, melatonin, serotonin, sleep, sound

With a $60,000 grant from FRAXA Research Foundation from 1998-1999, Dr. Randi Hagerman and her team at the University of California studied the effects of different compounds on individuals with Fragile X syndrome, focusing specifically on melatonin. Results published.

FMR1 Gene Regulation

FRAXA Research Foundation 1994-2000 Grants • Completed Research Grant • Disease Mechanisms • Genetic Rescue • Hagerman, Paul • University of California at Davis February 27, 2000April 25, 2018

With a $30,000 grant from FRAXA Research Foundation in 1999, Dr. Paul Hagerman and his team at the University of California researched how to re-activate the FMR1 gene and how to measure its levels.